In humans, early trials of NR and NMN show higher NAD levels and modest improvements in markers such as insulin sensitivity or arterial stiffness, but long-term, hard outcomes (for example, fewer age-related diseases or longer lifespan) are not yet proven
doi: 10.1016/j.tem.2015.05.011 174
Orforglipron 36 mg was also tied to greater odds of treatment discontinuation due to any adverse events (OR = 4.11
- Contains silymarin, which acts in the phase I of liver detoxification and functions as a strong antioxidant and liver toxicity protector
Neither peptide affects hormones or stimulates overstimulation of biological systems, making them suitable for long-term wellness strategies under professional supervision.
Increasing your dose Following the Mounjaro dosage schedule (a 2.5mg dose increase every 4 weeks), youll reach the maximum maintenance dose of 15mg on week 21 which youll stay on for the rest of your treatment